MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30

Today's Daily Dose brings you news about Moderna moving its COVID-19 vaccine candidate into phase III testing, Pfizer/BioNTech selecting BNT162b2 vaccine candidate for SARS COV-2 to advance into phase II/III trial, positive results from TCR2 Therapeutics' phase I/II trial of TC-210 for mesothelin-expressing solid tumors, and Spectrum Pharma's non-small cell lung cancer trial results.